Toll-like receptors are type-1 transmembrane receptors involved in microbial recognition. TLR4 has been shown to function as the lipopolysaccharide signaling receptor, while TLR2 recognizes peptidoglycans from Gram-positive bacteria, and lipoproteins. TLR9 is involved in the recognition of bacterial DNA (CpG DNA). Although various microbial cell wall components are recognized by different receptors, all of these responses are abrogated in MyD88-deficient cells. These results show that different TLRs recognize different microbial cell wall components, and that MyD88 is an essential signaling molecule shared among interleukin-1 receptor/Toll family members. However, in LPS signaling MyD88-independent pathway is present in addition to MyD88-dependent pathway.
Posttranscriptional control of mRNA regulates various biological processes, including inflammatory and immune responses. RNA-binding proteins (RBPs) bind cis-regulatory elements in the 3' untranslated regions (UTRs) of mRNA and regulate mRNA turnover and translation. In particular, eight RBPs (TTP, AUF1, KSRP, TIA-1/TIAR, Roquin, Regnase, HuR, and Arid5a) have been extensively studied and are key posttranscriptional regulators of inflammation and immune responses. These RBPs sometimes collaboratively or competitively bind the same target mRNA to enhance or dampen regulatory activities. These RBPs can also bind their own 3' UTRs to negatively or positively regulate their expression. Both upstream signaling pathways and microRNA regulation shape the interactions between RBPs and target RNA. Dysregulation of RBPs results in chronic inflammation and autoimmunity. Here, we summarize the functional roles of these eight RBPs in immunity and their associated diseases.
No abstract is provided for this article.
Interleukin 1 (IL 1), IL 6, and tumor necrosis factor (TNF) are typical examples of multifunctional cytokines involved in the regulation of the immune response, hematopoiesis, and inflammation. Their functions are widely overlapping but each shows its own characteristic properties. IL 6 was originally identified as a B cell differentiation factor, and thus one of the major functions of IL 6 is antibody induction. Transgenic mice have provided much needed information on the pathophysiological role of cytokines. With IL 6 transgenic mice, deregulation of the IL 6 expression was suggested to be involved in the generation of plasmacytoma/myeloma and mesangium proliferative glomerulonephritis. The cis-regulatory elements and trans-acting nuclear factor (or factors) for the IL 6 expression (NF-IL 6) have been identified. NF-IL 6 was shown to be a member of a C/EBP family, and the possible involvement of NF-IL 6 not only in the IL 6 regulation but also in the induction of various acute phase proteins was also observed. The findings suggest the presence of a positive regulatory loop in acute-phase reaction. IL 1 receptor belongs to an Ig superfamily, but the IL 6 receptor is a member of a newly identified cytokine receptor family. The IL 6 receptor system was shown to be composed of a ligand binding chain and a signal-transducing molecule. IL 6 was found to trigger the association of these two polypeptide chains. This unique mechanism may be applied to other cytokine receptor systems.
A problem in developing vaccine adjuvants is that their effectiveness may be inherently tied to TLR activation and consequently “cytokine storms”. To examine whether this applied to the TLR5 ligand flagellin, a MyD88-dependent adjuvant, we compared immune responses of TLR5KO mice and WT littermates to purified flagellin or flagellin+OVA. Flagellin-treated TLR5KO mice lacked induction of serum IL-12(p40), TNFα, RANTES, IL-17, Eotaxin, or MIP-1β measured over a 24 hour period compared to WT, yet had reduced though significant serum cytokine levels of KC (9%), IL-1α (53%), IL-6 (24%), MCP-1 (22%), and G-CSF (16%) (% KO of WT). TLR5KO mice also lacked detectable activation of splenic DC and had modestly diminished Ab titers to flagellin (26% of WT) or OVA (40% of WT). These data indicate flagellin’s adjuvanticity does not require TLR5, detectable DC activation, or the relatively high serum cytokine levels found in WT mice. In contrast, MyD88KO mice exhibited complete absence of flagellin-induced cytokines and Abs. Such data suggest the positive antibody response in TLR5KO mice may have resulted from a TLR5-independent pathway of flagellin recognition, whose activation and subsequent immune events promote adaptive immunity. These data support and expand the concept that TLR ligands can promote antibody responses by means not requiring the TLRs thought necessary for their innate immune recognition.